Structural Basis of a Novel Agonistic Anti-OX40 Antibody
Sign Up to like & getrecommendations! Published in 2022 at "Biomolecules"
DOI: 10.3390/biom12091209
Abstract: Agonistic antibodies targeting co-stimulating receptor OX40 on T cells are considered as important as (or complementary to) the immune checkpoint blockers in cancer treatment. However, none of these agonistic antibodies have reached the late stage… read more here.
Keywords: anti ox40; basis novel; structural basis; agonistic antibodies ... See more keywords